We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
-4.07%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$579M
AUM Growth
-$659K
Cap. Flow
+$36.9M
Cap. Flow %
6.37%
Top 10 Hldgs %
12.32%
Holding
351
New
26
Increased
68
Reduced
55
Closed
43

Top Buys

Rank Stock Value
1
FDX icon
FedEx
FDX
+$6.54M
2
VZ icon
Verizon
VZ
+$4.83M
3
AVGO icon
Broadcom
AVGO
+$4.75M
4
HPQ icon
HP
HPQ
+$4.12M
5
CI icon
Cigna
CI
+$3.49M

Top Sells

Rank Stock Value
1
NBR icon
Nabors Industries
NBR
+$6.79M
2
AMZN icon
Amazon
AMZN
+$5.75M
3
BIIB icon
Biogen
BIIB
+$4.42M
4
SBUX icon
Starbucks
SBUX
+$3.16M
5
BIDU icon
Baidu
BIDU
+$2.31M

Sector Composition

Rank Sector Weight
1 Technology 19.42%
2 Healthcare 16.94%
3 Consumer Discretionary 13.75%
4 Materials 10.81%
5 Consumer Staples 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVAX
226
DELISTED
Dynavax Technologies
DVAX
$809K 0.14%
+77,500
New +$1.01M
WPM icon
227
Wheaton Precious Metals
WPM
$60.9B
$809K 0.14%
25,000
-25,000
-50% -$821K
POWI icon
228
Power Integrations
POWI
$3.61B
$798K 0.14%
12,400
CPRX
229
DELISTED
Catalyst Pharmaceutical
CPRX
$795K 0.14%
62,000
-68,000
-52% -$806K
HRB icon
230
H&R Block
HRB
$5.86B
$791K 0.14%
18,600
-12,400
-40% -$525K
MU icon
231
Micron Technology
MU
$991B
$777K 0.13%
+15,500
New +$899K
MOV icon
232
Movado Group
MOV
$841M
$733K 0.13%
26,000
BIG
233
DELISTED
Big Lots, Inc.
BIG
$726K 0.13%
46,500
-31,500
-40% -$678K
ITCI
234
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$721K 0.12%
+15,500
New +$810K
CRSP icon
235
CRISPR Therapeutics
CRSP
$5.17B
$680K 0.12%
10,400
-10,400
-50% -$754K
CLX icon
236
Clorox
CLX
$12.7B
$668K 0.12%
5,200
HOPE icon
237
Hope Bancorp
HOPE
$1.79B
$657K 0.11%
52,000
ACI icon
238
Albertsons Companies
ACI
$5.83B
$646K 0.11%
26,000
LITE icon
239
Lumentum
LITE
$69.3B
$638K 0.11%
9,300
ACCO icon
240
Acco Brands
ACCO
$407M
$637K 0.11%
130,000
LCII icon
241
LCI Industries
LCII
$2.65B
$629K 0.11%
+6,200
New +$754K
ASB icon
242
Associated Banc-Corp
ASB
$5.91B
$622K 0.11%
31,000
HBB icon
243
Hamilton Beach Brands
HBB
$422M
$607K 0.1%
52,000
PETS icon
244
PetMed Express
PETS
$42.3M
$605K 0.1%
31,000
CHS
245
DELISTED
Chicos FAS, Inc.
CHS
$595K 0.1%
123,000
-31,000
-20% -$172K
FLGT icon
246
Fulgent Genetics
FLGT
$527M
$591K 0.1%
15,500
KRO icon
247
KRONOS Worldwide
KRO
$989M
$579K 0.1%
+62,000
New +$909K
AUY
248
DELISTED
Yamana Gold, Inc.
AUY
$566K 0.1%
125,000
EFOR
249
Everforth Inc
EFOR
$1.32B
$560K 0.1%
6,200
AGI icon
250
Alamos Gold
AGI
$13.9B
$556K 0.1%
75,000

Similar funds

Hussman Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Hussman Strategic Advisors held 351 positions worth $579M, down 0.11% from $580M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Hussman Strategic Advisors deployed $36.9M of net new capital in Q3 2022, opening 26 new positions and adding to 68 existing holdings. Its largest new stake was FedEx: 31,000 shares worth $4.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Nabors Industries, an estimated $6.79M trimmed.

  • Hussman Strategic Advisors's largest Q3 2022 buy was FedEx: 31,000 shares worth $4.6M.
  • Hussman Strategic Advisors added most to Verizon in Q3 2022, an estimated $4.83M increase.
  • Hussman Strategic Advisors's biggest Q3 2022 reduction was Nabors Industries, cutting an estimated $6.79M.
  • Hussman Strategic Advisors fully exited Biogen in Q3 2022, selling an estimated $4.42M.
  • Hussman Strategic Advisors's ten largest holdings make up 12% of its $579M portfolio in Q3 2022.
  • Hussman Strategic Advisors opened 26 new positions and closed 43 in Q3 2022.
  • Hussman Strategic Advisors's portfolio value fell 0.11% quarter-over-quarter to $579M.

Based on Hussman Strategic Advisors's 13F filing for Q3 2022, filed 2 Nov 2022.